<DOC>
	<DOC>NCT00879580</DOC>
	<brief_summary>The purpose of this study is to evaluate the morbidity, mortality, and efficacy of use of the Enterprise(TM) stent for the treatment of (ruptured or non-ruptured) intracranial aneurysms.</brief_summary>
	<brief_title>Enterprise Stent Aneurysm Treatment (ESAT) Study - France</brief_title>
	<detailed_description>Per the opinion of the Commission for the Evaluation of Products and Services (CEPP) in France, renewal is contingent upon setup of a prospective morbidity, mortality, and efficacy study. The objective is to follow the stented Subjects for at least 1 year and evaluate the device and practices. This will be a multicenter study involving up to 15 interventional neuroradiologists in France. Subjects presenting with ruptured or non-ruptured aneurysms for whom simple or balloon assisted endovascular treatment is considered impossible or insufficient by the interventional neuroradiologist.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patient implanted with one or more CODMAN ENTERPRISE™ stents and who present one or more ruptured or nonruptured intracranial aneurysms assessed by angiography Agreement to take part in the study by the patient, or a representative of the patient in case of patient inability, after being informed by the investigator and have received information letter. Minors &lt;18 years of age Patient implanted for the same aneurysm with a CODMAN ENTERPRISE™ stent in association with one or more stents from a different brand. Patient who does not accept to take part in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>aneurysm</keyword>
	<keyword>stent</keyword>
	<keyword>intracranial aneurysm</keyword>
	<keyword>Ruptured Intracranial Aneurysm</keyword>
</DOC>